PATIENTS will have speedier access to the latest treatments and innovations, NICE has pledged.
Launching its new five-year strategy, the NHS watchdog is focusing heavily on a commitment to "swiftness and flexibility", with a need to constantly monitor and react to change.
Guideline recommendations will be transformed into "dynamic, living" publications designed to be "useful, usable and rapidly updated".
The strategy places emphasis on forming "key strategic partnerships" to ensure guidance is used by health professionals, as well as helping to reduce inequalities and deliver improvements.
NICE also pledges to drive the research agenda and develop innovative and data-driven methods.
Technology, the report said, would be leveraged to "maximise our efficiency and impact". NICE promises to provide independent world-leading assessments of new treatments "at pace", to speed up access for patients and increase uptake. NICE chief executive Professor Gillian Leng said the organisation was committed to being more dynamic and working more collaboratively.
She said: "Our work to produce rapid Covid-19 guidelines during the pandemic has hastened our desire for change. We demonstrated that we can be flexible and fleet of foot, without losing the rigour of our work, and we will now look to embed that approach in our day-today work.
"The world around us is changing. New treatments and technologies are emerging at a rapid pace, with real-world data driving a revolution in evidence. We will help busy healthcare professionals to navigate these new changes and ensure patients have access to the best care and latest treatments."
Link: The NICE strategy 2021 to 2026
This page was correct at the time of publication. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.
Save this article
Save this article to a list of favourite articles which members can access in their account.
Save to library